| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |